Mankind Pharma (MANKIND) Share Price Rises 2.09% Today to Rs 2,418.45

Mankind Pharma Share Price is at Rs 2,418.45, up 2.09% today, with market capitalisation at Rs 97,850.38 Cr as of 12 October 2026 at 1:23:12 PM IST.

Mankind Pharma Share Price is in focus today after the stock rose 2.09% to Rs 2,418.45, adding Rs 49.45 from the previous close of Rs 2,369. The company’s market capitalisation stands at Rs 97,850.38 Cr, placing Mankind Pharma among the larger names in the healthcare pack by market value. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the move relevant as a clean price-rise event rather than a news-led reaction.

Mankind Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,418.45
Previous Close	Rs 2,369
Today's Move	Rs 49.45 (+2.09%)
Open	Rs 2,359.25
High	Rs 2,425.05
Low	Rs 2,359.25
Market Capitalisation	Rs 97,850.38 crore
Market Cap Category	Large Cap

For readers tracking Mankind Pharma Share Price Today, the move is important because the stock traded between Rs 2,359.25 and Rs 2,425.05, with the open also at Rs 2,359.25. In this Mankind Pharma Share Price update, the key task is to separate price action from fundamentals and sector context. Univest is watching how the move fits with valuation, profitability ratios and the broader healthcare peer set.

Mankind Pharma Ltd. (MANKIND) rose to Rs 2,418.45 from the previous close of Rs 2,369, a move of Rs 49.45 or 2.09%. The stock opened at Rs 2,359.25, reached a high of Rs 2,425.05, recorded a low of Rs 2,359.25.

Mankind Pharma Share Price moved higher in early trade and last traded at Rs 2,418.45, above the previous close of Rs 2,369. The stock opened at Rs 2,359.25, touched a low of Rs 2,359.25 and a high of Rs 2,425.05. The day change is Rs 49.45, equal to 2.09%, and Mankind Pharma Share Price Today is therefore showing a clear positive intraday move rather than a flat drift.

For Mankind Pharma Share Price Live tracking, the range matters because the stock stayed near the day’s upper band after opening below the prior close. Mankind Pharma Share Price News is being read today mainly through these price levels, not through a confirmed catalyst. Univest data confirms the rise, but it does not establish a company-specific trigger. That makes the stock a straightforward Mankind Pharma Share Price rise case for price-action monitoring, with the current market capitalisation of Rs 97,850.38 Cr adding size context before moving to valuation and fundamentals.

Mankind Pharma Ltd. (MANKIND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 97,850.38 crore
P/E Ratio	47.9x
P/B Ratio	5.82x
ROE	12.69%
ROCE	13.24%
EPS	Rs 49.45
Book Value Per Share	Rs 407.39
Dividend Yield	0.04%

Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 47.9x, P/B 5.82x, ROE 12.69%, ROCE 13.24%. These ratios show where the company stands today and are not a call to buy or sell.

Mankind Pharma Ltd. has a market capitalisation of Rs 97,850.38 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 47.9x, P/B at 5.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.5x, median ROE of 11.22%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	47.9x
Benchmark Median P/E	31.5x
Benchmark Average P/E	47.12x
Benchmark P/E Range	3.56x to 679.32x
Company P/B Ratio	5.82x
Benchmark Median P/B	2.83x
Company ROE	12.69%
Benchmark Median ROE	11.22%
Company ROCE	13.24%
Benchmark Median ROCE	13.1%
Company Market Capitalisation	Rs 97,850.38 crore
Benchmark Median Market Cap	Rs 709.64 crore

Mankind Pharma Ltd. (MANKIND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 47.9x, which is above the benchmark median of 31.5x, a difference of +52.06%. A P/E difference of this kind is a reference point rather than a recommendation.

Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.22%, a difference of +13.1%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is above the benchmark median of 13.1%, a difference of +1.07%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,21,539.16	34.85	4.87	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,47,576	84.64	14.02	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,77,251.42	81.27	19.75	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,231.65	24.65	4.13	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,09,796.85	100.42	19.47	18.31	18.2

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 47.9x compared with the displayed peer median of 81.27x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 97,850.38 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Mankind Pharma

• Mankind Pharma Share Price rose 2.09% today to Rs 2,418.45, keeping the stock active in price action screens on Univest.
• The move comes without a verified company-specific catalyst, so Mankind Pharma Stock News is being read mainly through intraday numbers.
• Valuation stays elevated versus the industry median, which keeps Mankind Pharma Fundamental Analysis relevant for readers.
• ROE of 12.69% and ROCE of 13.24% place the company near to slightly above the industry benchmark, adding context to Mankind Pharma Share Price Today.
• Peer comparison shows the stock between lower-multiple and high-multiple pharma names, making Mankind Pharma Share Price a useful benchmark name in Healthcare.

About Mankind Pharma

Mankind Pharma Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for a broad pharma presence, and Mankind Pharma Share Price often draws attention because the business sits in a sector where valuation and earnings quality are closely watched. As a listed company on NSE and BSE, Mankind Pharma remains part of the wider Indian Stock Market healthcare universe that includes large branded pharmaceutical names and specialty players.

For Mankind Pharma Stock Analysis, the important point is the company’s combination of market scale and valuation. Its market capitalisation stands at Rs 97,850.38 Cr, while the current ratio set includes P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Univest uses those figures to place Mankind Pharma Share Price in a broader company overview, helping readers compare the stock with other Pharmaceuticals & Drugs businesses without drifting into guesswork.

Frequently Asked Questions

What is Mankind Pharma Share Price today?

Ans. Mankind Pharma Share Price is Rs 2,418.45, up 2.09% today. The stock added Rs 49.45 from the previous close of Rs 2,369 and is trading with a market capitalisation of Rs 97,850.38 Cr.

Why is Mankind Pharma Share Price rising today?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. Mankind Pharma Share Price is therefore best read as a verified intraday rise rather than a news-linked move.

What was Mankind Pharma Share Price previous close?

Ans. The previous close for Mankind Pharma Share Price was Rs 2,369. Today’s move of Rs 49.45 took the stock to Rs 2,418.45, which helps frame the day’s share price rise clearly.

What is Mankind Pharma market capitalisation?

Ans. Mankind Pharma’s market capitalisation stands at Rs 97,850.38 Cr. That places Mankind Pharma Share Price in a sizeable listed healthcare company context, especially when compared with the benchmark industry median of Rs 709.64 Cr.

How does Mankind Pharma Share Price compare with industry valuation?

Ans. Mankind Pharma Share Price trades at a P/E of 47.9 and a P/B of 5.82. Both are above the same-industry medians of 31.5 and 2.83, giving the stock a higher valuation profile than the median peer.

What do ROE and ROCE show for Mankind Pharma?

Ans. Mankind Pharma reports ROE of 12.69% and ROCE of 13.24%. Both are slightly above the industry medians, so Mankind Pharma Share Price is supported by return metrics that are better than the benchmark median.

What are EPS and book value for Mankind Pharma Share Price?

Ans. EPS is Rs 49.45 and book value is Rs 407.39. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share, both important for Mankind Pharma Share Price analysis.

How does Mankind Pharma compare with peers?

Ans. Mankind Pharma Share Price has a market cap below Sun Pharma, Divi’s and Torrent, but close to Dr. Reddy’s and Aurobindo. Its P/E is above several peers, while ROE and ROCE remain broadly competitive.

Track Mankind Pharma Share Price on Univest

Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors tracking Mankind Pharma Share Price Today can follow live price updates, key valuation ratios, 52-week levels and market insights on Univest. The platform keeps Mankind Pharma Share Price, Mankind Pharma Stock News and Mankind Pharma Fundamental Analysis in one place so that readers can review price action, sector context and peer comparisons together.

If you are watching Mankind Pharma Share Price Live, Univest also helps you stay updated on market cap, earnings ratios and company context without mixing in unsupported conclusions. That makes MANKIND a practical name to track when Indian Stock Market healthcare movers are in focus.